These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29205277)

  • 21. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
    Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
    Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations of Kidney Dysfunction-Related Gene Variants in Sickle Cell Disease Patients in Cameroon (Sub-Saharan Africa).
    Ngo-Bitoungui VJ; Belinga S; Mnika K; Masekoameng T; Nembaware V; Essomba RG; Ngo-Sack F; Awandare G; Mazandu GK; Wonkam A
    Front Genet; 2021; 12():595702. PubMed ID: 33790942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
    Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
    OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.
    Lin RJ; Evans AT; Wakeman K; Unterbrink M
    Hemoglobin; 2015; 39(5):305-9. PubMed ID: 26114739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
    Adeyemo T; Ojewunmi O; Oyetunji A
    Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic determinants of haemolysis in sickle cell anaemia.
    Milton JN; Rooks H; Drasar E; McCabe EL; Baldwin CT; Melista E; Gordeuk VR; Nouraie M; Kato GR; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Rana S; Castro O; Zhang Y; Thein SL; Sebastiani P; Gladwin MT; ; Steinberg MH
    Br J Haematol; 2013 Apr; 161(2):270-8. PubMed ID: 23406172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.
    Rampersaud E; Kang G; Palmer LE; Rashkin SR; Wang S; Bi W; Alberts NM; Anghelescu D; Barton M; Birch K; Boulos N; Brandow AM; Brooke RJ; Chang TC; Chen W; Cheng Y; Ding J; Easton J; Hodges JR; Kanne CK; Levy S; Mulder H; Patel AP; Puri L; Rosencrance C; Rusch M; Sapkota Y; Sioson E; Sharma A; Tang X; Thrasher A; Wang W; Yao Y; Yasui Y; Yergeau D; Hankins JS; Sheehan VA; Downing JR; Estepp JH; Zhang J; DeBaun M; Wu G; Weiss MJ
    Blood Adv; 2021 Jul; 5(14):2839-2851. PubMed ID: 34283174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Leonardo FC; Brugnerotto AF; Domingos IF; Fertrin KY; de Albuquerque DM; Bezerra MA; Araújo AS; Saad ST; Costa FF; Menzel S; Conran N; Thein SL
    Br J Haematol; 2016 May; 173(3):456-60. PubMed ID: 26888013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.
    Qadah T; Noorwali A; Alzahrani F; Banjar A; Filimban N; Felimban R
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):705-710. PubMed ID: 33100714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between foetal haemoglobin and haematological indices in children with sickle cell anaemia from South Western Nigeria.
    Akinlosotu MA; Adegoke SA; Oseni SB; Adeodu OO
    Niger Postgrad Med J; 2017; 24(4):195-200. PubMed ID: 29355156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease.
    Zivot A; Apollonsky N; Gracely E; Raybagkar D
    J Pediatr Hematol Oncol; 2017 May; 39(4):314-317. PubMed ID: 28221266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.
    Tozatto-Maio K; Girot R; Ly ID; Silva Pinto AC; Rocha V; Fernandes F; Diagne I; Benzerara Y; Dinardo CL; Soler JP; Kashima S; Araujo IL; Kenzey C; Fonseca GHH; Rodrigues ES; Volt F; Jarduli L; Ruggeri A; Mariaselvam C; Gualandro SFM; Rafii H; Cappelli B; Nogueira FM; Scigliuolo GM; Guerino-Cunha RL; Malmegrim KCR; Simões BP; Gluckman E; Tamouza R
    Front Immunol; 2020; 11():2041. PubMed ID: 33013863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients.
    Ellithy HN; Yousri S; Shahin GH
    Hematology; 2015 Dec; 20(10):598-606. PubMed ID: 25880856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
    Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
    EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.